BRIEF-Fosun Pharmaceutical's Subsidiary Signs Agreement With Palleon

Reuters
19 Dec 2024
BRIEF-Fosun Pharmaceutical's Subsidiary Signs Agreement With Palleon

Dec 19 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:

  • SAYS SUBSIDIARY SHANGHAI HENLIUS BIOTECH INC SIGNS COLLABORATION AND LICENSING AGREEMENT WITH PALLEON PHARMACEUTICALS INC

Source text

Further company coverage: 600196.SS

(Reporting by Beijing Newsroom)

((yukun.zhang@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10